Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company that develops, manufactures, markets, and distributes a portfolio of medicines, including generics, injectables, biosimilars and specialty branded pharmaceuticals. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services. We show 24 historical shares outstanding datapoints in our coverage of AMRX's shares outstanding history.
Understanding the changing numbers of AMRX shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like AMRX versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching AMRX by allowing them to research AMRX shares outstanding history
as well as any other stock in our coverage universe. |
Free AMRX Email Alerts:
Video: Shares Outstanding Importance
